IL37 and type 2 diabetes mellitus: The study assessed the systemic immunological profiles of interleukin-23 (IL-23) and interleukin-35 (IL-35) in four participant groups: healthy controls, individuals with type 2 diabetes mellitus (T2DM) alone, individuals with periodontitis alone, and those with both T2DM and periodontitis [66].